Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study

by Hyams, D., Chan, Arlene, de Oliveira, C., Snyder, R., Vinholes, J., Audeh, M W., Alencar, V., Lombard, J., Mookerjee, B., Xu, J., Brown, K., Klein, P.
Published 2013